Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement GlobeNewswire - Thu Dec 4, 6:10AM CST

NEW YORK and SOUTH SAN FRANCISCO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. (Nasdaq: DNLI) today announced a $275 million synthetic royalty...

RPRX : 38.39 (-1.08%)
DNLI : 17.98 (+3.51%)
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement GlobeNewswire - Thu Dec 4, 6:00AM CST

SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty...

RPRX : 38.39 (-1.08%)
DNLI : 17.98 (+3.51%)
CHD
3 Mid-Cap Stocks That Concern Us StockStory - Wed Dec 3, 10:33PM CST

3 Mid-Cap Stocks That Concern Us

RPRX : 38.39 (-1.08%)
FHN : 23.59 (-0.92%)
CHD : 84.61 (+1.24%)
Royalty Pharma to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 26, 7:15AM CST

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December: ...

RPRX : 38.39 (-1.08%)
ST
3 Value Stocks with Warning Signs StockStory - Mon Nov 17, 10:41PM CST

3 Value Stocks with Warning Signs

ST : 34.78 (-3.39%)
RPRX : 38.39 (-1.08%)
OMC : 80.25 (+0.22%)
CBRL
3 Low-Volatility Stocks We Find Risky StockStory - Sun Nov 16, 10:44PM CST

3 Low-Volatility Stocks We Find Risky

RPRX : 38.39 (-1.08%)
ACT : 39.74 (+1.04%)
CBRL : 27.33 (-3.19%)
RPRX
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? StockStory - Wed Nov 12, 10:03PM CST

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings?

RPRX : 38.39 (-1.08%)
Royalty Pharma Reports Third Quarter 2025 Results GlobeNewswire - Wed Nov 5, 6:00AM CST

Portfolio Receipts growth of 11% to $814 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $703 million Raised full year 2025 guidance: Portfolio Receipts expected...

RPRX : 38.39 (-1.08%)
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences GlobeNewswire - Tue Nov 4, 6:15AM CST

NEW YORK and CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in Alnylam’s AMVUTTRA from funds managed by...

RPRX : 38.39 (-1.08%)
RPRX
Spotting Winners: Royalty Pharma (NASDAQ:RPRX) And Branded Pharmaceuticals Stocks In Q2 StockStory - Mon Nov 3, 9:34PM CST

Spotting Winners: Royalty Pharma (NASDAQ:RPRX) And Branded Pharmaceuticals Stocks In Q2

RPRX : 38.39 (-1.08%)

Barchart Exclusives

How to Make a 1.77% 1-Month Yield in GOOGL Stock - It Still Looks Undervalued Barchart - Sun Dec 14, 8:30AM CST
Out-of-the-money (OTM) GOOGL put options can provide short sellers a 1.77% one-month yield. Moreover, GOOGL stock has +32% upside based on an FCF-based target. Buying in-the-money calls is another play. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot